In rheumatic-disease inpatients, depot tetracosactrin acted virtually twice as long as corticotrophin gel, with about 0.25 mg corresponding to 50 units.
In plain wordsIn rheumatic-disease inpatients, depot tetracosactrin acted almost twice as long as corticotrophin gel.
- Peptide
- Cosyntropin
- Outcome
- IncreaseDuration of action
- Study
n = 12
- Comparator
- Corticotrophin gel
- Outcome group
- Adrenal Function · Endocrine and hormones
- Studied dose
- about 0.25 mg depot tetracosactrin to 50 units of corticotrophin gel (stated dose relationship) · subcutaneousAs given in this study (human).
Source sentences
The duration of action of the depot tetracosactrin was virtually twice that of corticotrophin gel, the dose relationship being about 0.25 mg. of depot tetracosactrin to 50 units of gel.
1 context sentence(design, population, supporting numbers)
Depot tetracosactrin has been compared with corticotrophin gel in 12 inpatients of a rheumatic diseases unit Every patient received one subcutaneous infection each of the synthetic and the animal preparation